Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Austria | European Medicines Agency | Hong Kong | India | Malaysia | Norway | Poland
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
02/23/2024 |
PubMed |
Atypical case of subcutaneous filariosis in a cat caused by Dirofilaria immitis. |
|
02/01/2024 |
PubMed |
Apparent tick paralysis by Otobius megnini in a cat. |
|
01/01/2024 |
PubMed |
SARCOPTIC MANGE IN FREE-RANGING NORTH AMERICAN PORCUPINES (ERETHIZON DORSATUM) IN NEW YORK STATE. |